| Previous ID Next ID Search for '144626179' |
5001: Papers(Old)
|
|
|---|---|
| DOI | 10.3390/pharmaceutics15030885 |
| category | 2 |
| imaging | 0.6390150189399719 |
| therapy | 0.6930580139160156 |
| modeling | 0.5172494053840637 |
| wos_citations | 2 |
| scopus_citations | 3 |
| COBISS | 144626179 |
| group | |
| classification | |
| title | |
| ISSN | |
| authors | |
|
5002: Papers
|
|
| DOI | 10.3390/pharmaceutics15030885 |
| category | 2 |
| imaging | 0.6663586497306824 |
| therapy | 0.6810660362243652 |
| modeling | 0.5819119513034821 |
| year | 2023 |
| citedness | 6.199787742106659 |
| wos_citations | 3 |
| scopus_citations | 4 |
| COBISS | 144626179 |
| group | |
| classification | 1.01 |
| title | Development of the 99mTc-labelled SST2 antagonist TECANT-1 for a first-in-man multicentre clinical study |
| ISSN | 1999-4923 |
| authors | 31672;23364;50623 |
| exclude | |
| firstAuthor | 50623 |
| MR | false |
| MRcoAuthor | false |
 |
|
|
|